Kilpeläinen et al. [42] reported a locus near IRS1 which was associated with a decrease in BF but with an impaired metabolic profile, including increased insulin resistance, dyslipidemia, risk of diabetes and coronary artery disease, and decreased adiponectin levels. Here, ADIPOQ is linked to Insulin resistance.